v3.26.1
Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Shares
Additional Paidin Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2022 $ 387 $ 601,105 $ 387 $ (331,096) $ 270,783
Beginning balance (in shares) at Dec. 31, 2022 29,873,893        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options   681     681
Issuance of ADSs upon exercise of share options (in shares) 54,023        
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses $ 162 249,183     249,345
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses (in shares) 12,384,706        
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 119,144        
Share-based compensation expense   32,477     32,477
Foreign currency translation adjustment     (1,691)   (1,691)
Net Income (Loss)       (180,664) (180,664)
Ending balance at Dec. 31, 2023 $ 550 883,446 (1,304) (511,760) 370,932
Ending balance (in shares) at Dec. 31, 2023 42,431,766        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options $ 8 7,519     7,527
Issuance of ADSs upon exercise of share options (in shares) 554,596        
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses $ 331 543,796     544,127
Issuance of ADSs and non-voting ordinary shares, net of commissions and offering expenses (in shares) 25,933,706        
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 141,350        
Share-based compensation expense   38,081     38,081
Foreign currency translation adjustment     1,423   1,423
Net Income (Loss)       (169,031) (169,031)
Ending balance at Dec. 31, 2024 $ 890 1,472,842 119 (680,791) $ 793,060
Ending balance (in shares) at Dec. 31, 2024 69,061,418       69,061,418
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options   33     $ 33
Issuance of ADSs upon exercise of share options (in shares) 10,116        
Issuance of ADSs upon settlement of restricted share units $ 4       4
Issuance of ADSs upon settlement of restricted share units (in shares) 296,362        
Share-based compensation expense   39,464     39,464
Foreign currency translation adjustment     (3,624)   (3,624)
Net Income (Loss)       (218,960) (218,960)
Ending balance at Dec. 31, 2025 $ 894 $ 1,512,339 $ (3,505) $ (899,751) $ 609,977
Ending balance (in shares) at Dec. 31, 2025 69,367,896       69,367,896